Bidica

Bidica

Manufacturer:

Pacific Pharma

Distributor:

AA Medical
Concise Prescribing Info
Contents
Biphenyl dimethyl dicarboxylate
Indications/Uses
Chronic & persistent hepatitis associated w/ high ALT levels or drug-induced high transaminase levels.
Dosage/Direction for Use
Special Precautions
Patients w/ chronic active hepatitis & cirrhosis. Patients whose ALT rises during administration of Bidica: ALT can increase after the end of administration, but it can be improved through re-administration of Bidica. Nausea may occur rarely. Pregnancy & lactation. Childn. Elderly.
Adverse Reactions
Administer w/ anti-hypersensitivity agent if thirst, nausea, rash occurs. Discontinue administration w/ treatment for jaundice if temporary jaundice occurs. Nausea & abdominal distention can occur rarely.
Drug Interactions
MIMS Class
Cholagogues, Cholelitholytics & Hepatic Protectors
ATC Classification
A05BA - Liver therapy ; Used in liver therapy.
Presentation/Packing
Form
Bidica tab 25 mg
Packing/Price
12 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in